Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Details)

v3.4.0.3
Segment Reporting (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Mar. 31, 2016
Mar. 31, 2015
Jun. 30, 2015
Segment Reporting Information [Line Items]          
Net revenues $ 379 $ 349 $ 673 $ 1,535  
Research and development expenses 1,048 815 2,303 2,731  
General and administrative expenses 2,403 1,222 5,509 3,574  
Operating loss (3,072) (1,688) (7,139) (4,770)  
Total assets 50,665   50,665   $ 12,494
iBio Brazil [Member]          
Segment Reporting Information [Line Items]          
Net revenues 0 0 0 0  
Research and development expenses 0 0 0 0  
General and administrative expenses 5 35 17 86  
Operating loss (5) (35) (17) (86)  
Total assets 23   23   46
iBio United States [Member]          
Segment Reporting Information [Line Items]          
Net revenues 379 349 673 1,535  
Research and development expenses 1,048 815 2,303 2,731  
General and administrative expenses 2,398 1,187 5,492 3,488  
Operating loss (3,067) $ (1,653) (7,122) $ (4,684)  
Total assets $ 50,642   $ 50,642   $ 12,448